Sep 9, 2013 |
Dr. Rodgers discusses how clinical trials offer hope for people with type 2 diabetes and shares information about the GRADE study.
For nearly 26 million Americans who have diabetes, clinical trials offer hope.
Hi, I’m Dr. Griffin Rodgers, Director of the National Institute of Diabetes and Digestive and Kidney Diseases at NIH.
One such trial is GRADE – a long-term study of different treatments for type 2 diabetes.
In time, many people with type 2 diabetes need two drugs to help control their blood sugar. One challenge is figuring out the best second drug for people already on metformin, the most commonly used diabetes drug.
GRADE is looking at four different types of drugs – all FDA approved and recommended by the American Diabetes Association – that could be used next with metformin.
Right now, it’s not clear which combination of two drugs is best for controlling diabetes in a given individual. GRADE researchers at 37 sites across the U.S. hope to find an answer.
To learn more, follow us on Twitter @HealthyMoments. This is Dr. Griffin Rodgers with the NIH.